- 1.Sixty-six (66) (70.2%) of the patients were male, with 42.6% having premature coronary artery disease (<60 years of age).
- 2.Fifty-one (51) (54.3%) had elevated LDL-C (≥2 mmol/L), and 47 (50%) elevated triglycerides (≥ 1.7 mmol/L), and 59 (62.8%) reduced HDL-C (<1 mmol/L).
- 3.Twenty-nine (29) (30.9%) had elevated plasma Lp(a), (≥105 nmol/L), and 38 (40.4%) had elevated REM-C, (≥0.9 mmol/L). 13.8% had both elevated Lp(a) and LDL-C, 16.0% had both elevated LDL-C and REM-C, and 3.2% had both elevated Lp(a) and REM-C. Eight (8) patients (8.5%) had elevated Lp(a), LDL-C and REM-C. Overall, only 9.6% of the cohort had optimal levels for LDL-C, triglycerides, HDL-C [], Lp(a) [,] and REM-C [,].
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Contribution of remnant cholesterol to cardiovascular risk.J Intern Med. 2020; 288: 116-127
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.Eur Heart J. 2020; 41: 111-188
- Lp(a) (Lipoprotein[a]) Concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank.Arterioscler Thromb Vasc Biol. 2021; 41: 465-474
- Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.Lancet. 2018; 392: 1311-1320
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.Eur Heart J. 2021; 42: 4324-4332
- Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population.Clin Chem. 2015; 61: 533-543